Longitudinal morphological changes during recovery from brain deformation due to idiopathic normal pressure hydrocephalus after ventriculoperitoneal shunt surgery. by YAMADA Shigeki et al.
Longitudinal morphological changes during
recovery from brain deformation due to
idiopathic normal pressure hydrocephalus after
ventriculoperitoneal shunt surgery.
著者 YAMADA Shigeki, ISHIKAWA Masatsune, YAMAGUCHI
Makoto, YAMAMOTO Kazuo
journal or
publication title
Scientific reports
volume 9
number 1
page range 17318
year 2019-11-21
URL http://hdl.handle.net/10422/00012585
doi: 10.1038/s41598-019-53888-7(https://doi.org/10.1038/s41598-019-53888-7)
(C) The Author(s) 2019
This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format,
as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The images or other third party material
in this
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit
line to the material. If material is not included in the article’s Creative Commons license and your
intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to
obtain permission directly from the copyright holder. To view a copy of this license, visit
http://creativecommons.org licenses/by/4.0/.
1Scientific RepoRtS |         (2019) 9:17318  | https://doi.org/10.1038/s41598-019-53888-7
www.nature.com/scientificreports
Longitudinal morphological 
changes during recovery from brain 
deformation due to idiopathic 
normal pressure hydrocephalus 
after ventriculoperitoneal shunt 
surgery
Shigeki Yamada  1,2,3*, Masatsune ishikawa2,4, Makoto Yamaguchi2 & Kazuo Yamamoto2
The present study aimed to examine time-dependent change in cerebrospinal fluid distribution and 
various radiological indices for evaluating shunt effectiveness in patients with idiopathic normal 
pressure hydrocephalus (iNPH). This study included 54 patients with iNPH who underwent MRI before 
and after ventriculoperitoneal shunt surgery. the volume of the total ventricles and subarachnoid 
spaces decreased within 1 month after shunting. However, more than 1 year after shunting, the volume 
of the total ventricles decreased, whereas that of the total subarachnoid spaces increased. Although 
cerebrospinal fluid distribution changed considerably throughout the follow-up period, the brain 
parenchyma expanded only 2% from the baseline brain volume within 1 month after shunting and 
remained unchanged thereafter. the volume of the convexity subarachnoid space markedly increased. 
the changing rate of convexity subarachnoid space per ventricle ratio (cVR) was greater than that 
of any two-dimensional index. The brain per ventricle ratio (BVR), callosal angle and z-Evans index 
continued gradually changing, whereas Evans index did not change throughout the follow-up period. 
Both decreased ventricular volume and increased convexity subarachnoid space volume were important 
for evaluating shunt effectiveness. Therefore, we recommend CVR and BVR as useful indices for the 
diagnosis and evaluation of treatment response in patients with inpH.
Normal pressure hydrocephalus (NPH) was first proposed by Hakim and Adams as a surgically treatable cause 
of dementia in 19651. With the development of imaging predictors of shunt effectiveness, the prevalence of idi-
opathic NPH (iNPH) has been increasing rapidly in developed countries characterized by a higher proportion 
of the elderly population1–8. Additionally, recent developed devices, such as adjustable valves with anti-siphon 
mechanisms, preoperative virtual simulators, and several intraoperative guiding tools, have improved the out-
come of shunt surgery; approximately 70% of patients improve their symptoms to some extent9–13, and 10% of 
patients need shunt revision10,11,14. However, the symptoms of 30% of patients with iNPH who undergo shunt 
surgery are not improved for various reasons, including underdrainage, shunt malfunction, and comorbidi-
ties. If a patient’s symptoms do not improve or even worsen after shunt surgery, neurosurgeons must investigate 
the cause by computed tomography (CT) or magnetic resonance imaging (MRI). However, it is unknown how 
iNPH-specific indices change following shunt surgery.
According to Hakim’s hypothesis15, brain shrinkage due to compression from enlarged ventricles in NPH 
can be reverted by cerebrospinal fluid (CSF) volume subtraction. Indeed, in typical patients with secondary or 
congenital NPH, the brain parenchyma obviously expands as ventricular size decreases after CSF shunt surgery 
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(Fig. 1A–D)16,17. However, the ventricular size measured by the Evans index remains often unchanged in elderly 
patients with iNPH (Fig. 1E,F), even if their symptoms are improved after shunting18–21. The key features of iNPH 
are compressed high-convexity sulci concurrent with enlarged Sylvian fissure and basal cistern, i.e., dispropor-
tionately enlarged subarachnoid space hydrocephalus (DESH)4,22–24. We recently showed that the pathophys-
iological mechanism of DESH in iNPH mainly involves the compensatory direct pathway of CSF between the 
inferior horn of the lateral ventricles and the basal cistern at the inferior choroidal point of the choroidal fissure16. 
Therefore, if the lateral ventricles and the basal cistern in iNPH are enlarged simultaneously, they may all become 
smaller following shunt surgery. Depending on the decrease in the volumes of the lateral ventricles and the basal 
cistern, the volume of the convexity subarachnoid space may increase. Therefore, we investigated the longitudinal 
change in iNPH-specific indices and the volumes in the brain parenchyma, ventricles, and subarachnoid spaces 
on three-dimensional (3D) MRI before and after shunt surgery. Additionally, because the presence of comorbid 
Alzheimer’s disease (AD) is associated with smaller, shorter-lasting effects of shunt treatment in patients with 
iNPH25–27, we also investigated whether the change in the indices and volumes is associated with clinical out-
comes or comorbid AD.
Results
clinical characteristics. In 54 consecutive patients with iNPH who underwent follow-up MRI within 1 
month after ventriculo-peritoneal shunt (VPS) via parieto-occipital approach (mean age, 76.7 ± 5.8 years; range, 
60 to 88 years; 35 men, 19 women), the longitudinal changes in the morphological indices for iNPH and the 
segmented volumes in brain parenchyma and CSF spaces were evaluated. The mean time interval from initial 
symptom onset until baseline MRI (before VPS) was 27.3 ± 19.7 months, and that from initial symptom onset 
until VPS was 48.7 ± 69.1 months. Follow-up MRI was conducted < 1 month (early) after VPS in all 54 patients, 
1 month to 1 year (mid) in 28 patients, and > 1 year (late) in 16 patients. Table 1 presents the baseline clinical 
characteristics and outcome after VPS. The first 12 patients treated with a Codman Hakim programmable valve, 
whereas the latter 42 patients treated with a Codman CERTAS Plus programmable valve. There was no significant 
difference between the two groups in the mean values of age, disease duration, or frequency of co-morbidities and 
outcome. As shown in Table 2, the patients with pure iNPH had significantly larger Evans index and significantly 
Figure 1. Conventional CT scan one day before and one month after shunt surgery. Representative cases 
diagnosed with adult-onset congenital NPH (A,B), secondary NPH (C,D) and idiopathic NPH (E,F).
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smaller brain per ventricle ratios (BVRs) at the posterior commissure (PC) level at baseline MRI than those with 
co-occurrence of iNPH and AD. The other the iNPH-specific indices and segmented CSF volumes were not sig-
nificantly different between patients with pure iNPH and those with co-occurrence of iNPH and AD.
changes in morphological indices after shunt implantation. The mean value of the Evans index 
remained unchanged throughout the follow-up period, whereas that of the z-Evans index showed gradual and 
slight decrease (Table 3 and Fig. 2A). The mean rate of change in the BVR at the anterior commissure (AC) level 
was more than two-fold than that of the z-Evans index but less than that of the BVR at the PC level. The mean rate 
of change in the callosal angle was the largest among the two-dimensional (2D) parameters: it was 13% early after 
VPS, and then increased to > 30% late after VPS.
Volumetric changes. At the early phase after VPS, the mean volume of the total intracranial CSF decreased 
by 24 ± 39 mL from the baseline due to the decrease both in the total ventricles (19 mL) and the total subarach-
noid spaces (5 mL), as shown in Table 3. Conversely, the brain volume slightly increased just as much as intracra-
nial CSF decreased, but subsequently there was no further increase in the brain volume throughout the follow-up 
period (Table 3 and Fig. 2B). At the mid phase after VPS, the mean volumes of the total ventricles and the total 
subarachnoid spaces were almost unchanged. At the late phase, however, the mean rate of change in the total ven-
tricular volume decreased < 20% again, whereas that of the total subarachnoid spaces increased < 10%. The mean 
volume of the Sylvian fissure and basal cistern gradually and slightly decreased from 130 mL to 100 mL at the late 
phase after VPS (Table 3 and Fig. 2C). In contrast, the mean volume of the convexity subarachnoid space consid-
erably increased > 60% late after VPS. The changing rate of the convexity subarachnoid space per ventricle ratio 
(CVR), which was calculated as the volume of the convexity subarachnoid space divided by the total ventricular 
volume, was greater than that of any 2D index (Fig. 2A).
Relationship with clinical outcome. Among the iNPH-specific indices, the BVRs at the AC and PC levels 
late after VPS had a statistically significant difference between excellent and good outcomes (Fig. 3A). The mean 
volume of the total ventricles in the patients with excellent outcome continued gradually decreasing throughout 
the follow-up period, whereas that in the patients with good outcome conversely increased at the mid phase after 
VPS (Fig. 3B). However, the mean volume of the convexity subarachnoid space in the patients with excellent 
outcome gradually increased until late after VPS, whereas that in the patients with good outcome had a small 
increase (Fig. 3C). Although the patients with pure iNPH tended to have higher changing rates of the morpho-
logical indices and segmented volumes than those with co-occurrence of iNPH and AD, there was no statistical 
difference (Fig. 4).
Discussion
Our results indicated that the brain of patients with iNPH expanded <30 mL, which was <2% of the total brain 
volume, due to a decrease in the intracranial CSF volume just after shunt surgery, but subsequently remained 
unchanged throughout the follow-up period regardless of improved symptoms gradually. In addition, the dispro-
portionate CSF distribution specific to iNPH reverted to a normal distribution in three phases after shunting as 
shown in Fig. 5. Early after shunting, both the total ventricles and total subarachnoid spaces had reduced volumes, 
whereas the convexity part of the subarachnoid space had increased volume. Subsequently, mid after shunting, 
both the total ventricles and total subarachnoid spaces showed unchanged volumes despite continuous redis-
tribution of the intracranial CSF from the Sylvian fissure and basal cistern to the convexity subarachnoid space. 
Late after shunting, the total ventricles had reduced volumes again, but the total subarachnoid spaces had con-
versely increased volumes. However, the callosal angle and BVRs at the AC and PC levels showed gradual increase 
throughout the follow-up period, independent of the staged changes in the CSF distribution. These findings indi-
cated that the CSF shunt surgery in patients with iNPH causes the convexity part of the brain to move from top to 
Characteristics
Total 
(n = 54)
CHPV (n = 12) 
~3. 2016
CERTUS (n = 42) 
4. 2016~ P value*
Sex, men:women 35:19 9:3 26:16 0.542
Mean age ± SD, years 76.7 ± 5.8 75.2 ± 6.9 77.1 ± 5.3 0.220
Mean disease duration ± SD, years 2.3 ± 1.6 1.5 ± 1.1 2.5 ± 1.7 0.067
Mean days from MRI to shunt surgery 48.8 ± 69.1 39.7 ± 29.1 51.3 ± 76.9 0.906
Mean days from shunt surgery to the first follow-up MRI 12.2 ± 5.1 9.8 ± 2.6 12.9 ± 5.5 0.063
Comorbidity of Alzheimer’s disease 19 2 17 0.238
Outcome, excellent:good:unsatisfactory 43:11:0 8:4:0 35:7:0 0.217
Valve pressure at the first follow-up MRI 14.8 ± 3.9 mmH2O 4.5 ± 1.0
Valve pressure at the second follow-up MRI 13.6 ± 3.7 mmH2O 4.1 ± 0.9
Valve pressure at the third follow-up MRI 9.3 ± 2.8 mmH2O 3.4 ± 0.9
Table 1. Clinical characteristics and outcome after shunt surgery. Data are presented as the mean ± standard 
deviation unless otherwise noted. *Probability value of the Wilcoxon rank-sum test: comparison between 
CHPV vs. CERTUS. CERTUS, Codman CERTAS® Plus programmable valve with Siphon-Guard®; CHPV, 
Codman Hakim programmable valve with Siphon-Guard®; MRI, magnetic resonance imaging; SD, standard 
deviation.
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bottom and to regain normal shape via redistribution of intracranial CSF from the ventricles and Sylvian fissure to 
the convexity subarachnoid space rather than via brain expansion (i.e., like a sponge). We also demonstrated that 
the Evans index remained absolutely unchanged throughout the follow-up period. These results are in line with 
those of previous studies18–21,28,29. Some reports indicated that the Evans index was not appropriate for evaluating 
the ventricular size in elderly individuals, especially under the diagnosis of iNPH7,8,30–32. Therefore, these findings 
lead us to concluded that the BVRs at the AC and PC levels or z-Evans index which indicate the z-axial expan-
sion of the bilateral ventricles were appropriate for evaluating ventricular dilatation and shunt effectiveness in 
patients with iNPH, rather than the Evans index. Additionally, this study revealed that the morphological recovery 
from brain deformation after shunting was greater posteriorly than anteriorly. Among the 2D indices, the greatest 
changing rate was that of the callosal angle, followed by was the BVR at the PC level. Recently, Virhammar et al. 
reported that the callosal angle significantly increased 3 months after shunting21. In this study, the increase in the 
both BVRs at the AC and PC levels more than 1 year after shunting was significantly associated with the excellent 
outcome, although the changing rate in the BVR at the PC level was larger than that of the BVR at the AC level. 
These findings help to clarify the process of recovery from the symptoms and disproportionate CSF distribution 
in patients with iNPH after CSF shunt surgery. Additionally, the time-course of the redistribution of the intracra-
nial CSF after shunting may contribute to the next approach to adjust programmable valve pressure setting at the 
proper timing. For example, the total ventricles in the patients with excellent outcome continued slightly decreas-
ing throughout the follow-up period, whereas those in the patients with good outcome conversely increased at 
the mid phase after shunting. Even if the shunt valve pressure was appropriate early after shunting, it was actually 
underdrainage at the mid phase. Because increased ventricular volume after shunting may affect the outcome, we 
suggest physicians try to lower the shunt valve pressure mid after shunting, if iNPH-related symptoms persist with 
poor changes in the volume of total ventricle and BVRs at the AC and PC levels.
Our study has some limitations. First, there was a wide range of SDs for the mean values of assessment meas-
ures, because of varied size of the ventricles and subarachnoid spaces in patients with iNPH. Therefore, the 
changes in the indices and segmented CSF volumes have a possibility of large uncertainty. Second, the influence of 
MRI artefacts due to the shunt valve was small but could not be ignored; nevertheless, we measured the intracra-
nial CSF volume after VPS in patients with shunt valve placement under the occipital scalp. Third, a comorbidity 
of AD was not confirmed pathologically by brain biopsy, CSF biomarkers or amyloid imaging. Additional infor-
mation could increase the diagnostic accuracy of AD comorbidity26,27,33, although CSF biomarkers at the spinal 
tap test in iNPH were fluctuate and it is difficult to determine clear cutoff values of them between pure iNPH and 
iNPH + AD34. Finally, the participants in this study did not undergo MRI at the scheduled time-point. There is a 
possibility of the selection bias that the timing of follow-up MRI was not fixed. Therefore, several novel findings 
in this study should be further assessed in a prospective cohort study with scheduled timing of follow-up MRI.
In conclusion, the brain parenchyma expanded only 2% from the baseline brain volume early after shunt-
ing and remained subsequently unchanged, although CSF distribution considerably changed throughout the 
follow-up period. Changes in CSF distribution occurred in three phases after shunt implantation. The ventricu-
lar volume decreased at the early and late phases, whereas the volume of the total subarachnoid spaces slightly 
Characteristics
Total 
(n = 54)
Pure iNPH 
(n = 35)
iNPH + AD 
(n = 19) P value*
Evans index (mean ± SD) 0.32 ± 0.06 0.34 ± 0.06 0.30 ± 0.05 0.017
z-Evans index (mean ± SD) 0.44 ± 0.06 0.45 ± 0.06 0.43 ± 0.06 0.173
Callosal angle (mean ± SD) 63.5 ± 18.5 61.6 ± 19.6 67.1 ± 16.2 0.193
BVR at the AC (mean ± SD) 0.72 ± 0.17 0.70 ± 0.17 0.77 ± 0.18 0.133
BVR at the PC (mean ± SD) 0.89 ± 0.23 0.82 ± 0.19 1.00 ± 0.24 0.010
CVR (mean ± SD) 0.47 ± 0.20 0.47 ± 0.21 0.48 ± 0.18 0.812
Total intracranial volume, mL 1543 ± 156 1562 ± 123 1509 ± 203 0.296
Brain parenchyma, mL (VR, %) 1107 (71.8) 1119 (71.7) 1084 (72.0) 0.388
Total CSF, mL (VR, %) 436.8 (28.2) 443.3 (28.3) 424.9 (28.0) 0.683
Total ventricle, mL (VR, %) 163.7 (10.5) 170.5 (10.9) 151.1 (9.9) 0.108
Bilateral ventricle, mL (VR, %) 155.0 (10.0) 161.5 (10.3) 143.0 (9.4) 0.126
Third ventricle, mL (VR, %) 5.2 (0.3) 5.3 (0.3) 5.0 (0.3) 0.442
Fourth ventricle, mL (VR, %) 3.6 (0.2) 3.7 (0.2) 3.5 (0.2) 0.946
Total SAS, mL (VR, %) 273.1 (17.7) 272.7 (17.4) 273.8 (18.1) 0.651
Convex part of the SAS, mL (VR, %) 72.3 (4.7) 75.3 (4.8) 66.8 (4.4) 0.159
Sylvian fissure and basal cistern, mL (VR, %) 130.2 (8.4) 127.0 (8.1) 136.1 (9.0) 0.350
SAS in the posterior fossa, mL (VR, %) 70.6 (4.6) 70.1 (4.5) 71.3 (4.7) 0.788
Table 2. Morphological indices, volumes, and VR at baseline MRI. *Probability value of the Wilcoxon rank-
sum test: comparison between pure iNPH and iNPH + AD. iNPH + AD indicates patients with iNPH who had 
AD as comorbidity. VR, volume ratio which is calculated as the volume divided by the total intracranial volume. 
AC, anterior commissure; AD, Alzheimer’s disease; BVR, brain per ventricle ratio; CSF, cerebrospinal fluid; 
CVR, convex subarachnoid space to ventricle ratio; iNPH, idiopathic normal pressure hydrocephalus; MRI, 
magnetic resonance imaging; PC, posterior commissure; SAS, subarachnoid space; SD, standard deviation; VR, 
volume ratio.
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decreased at the early phase, conversely increasing at the late phase. Especially, the volume of the convexity sub-
arachnoid space markedly increased throughout the follow-up period. Both decreased ventricular volume and 
increased convexity subarachnoid space volume were important for evaluating shunt effectiveness. Therefore, 
we recommend CVR, which can measure directly the volumetric change both in the ventricles and convexity 
subarachnoid space, as a 3D index. However, a 3D index is difficult to measure in clinical routine. As simple 2D 
indices, the callosal angle, BVR at the PC level, BVR at the AC level, and z-Evans index were greatly changed after 
shunt surgery (in that order), whereas the Evans index remained unchanged throughout the follow-up period. 
Among them, we recommend the BVRs at the AC and PC levels, because they were significantly associated with 
better clinical outcomes or comorbid AD. These novel findings may contribute to future studies of the pathogen-
esis of iNPH and to developing a future treatment approach based on the specific CSF distribution in patients 
with iNPH.
Methods
ethical approval and patient consent. The study design and protocol were approved by the ethics com-
mittee for human research at Rakuwakai Otowa Hospital (IRB Number: Rakuoto-Rin-14-003). After the patients 
or their relatives provided written informed consent, their private information was anonymized in a linkable 
manner. The methods were performed in accordance with the approved guidelines outlined in the Declaration 
of Helsinki.
Study population. Details of the clinical data collection, image acquisition, and segmentation and quan-
tification of the ventricles and subarachnoid spaces are described in our previous publications7,8,16. Volumetric 
data of T2-weighted 3D-SPACE sequence were prospectively collected from November 2013 to June 2018 on 
3-Tesla MRI scanner (MAGNETOM Skyra; Siemens AG, Muenchen, Germany) before and after VPS surgery 
in consecutive 72 patients diagnosed with iNPH. Three patients who underwent VPS via frontal approach were 
excluded, because the artefacts from the metal parts in the shunt valve affected the volumetric analysis on MRI. 
Three patients who underwent lumboperitoneal shunt surgery were excluded, because the different locations of 
CSF drainage might influence changes in CSF distribution after shunt surgery. Two patients who were diagnosed 
with shunt malfunction and required shunt revision about 1 year after the first shunt surgery were excluded, 
because we cannot judge when the shunt was obstructed, or how long it was effective. Additionally, 10 patients 
who underwent the first follow-up MRI > 1 month after VPS were excluded. Finally, 54 patients with iNPH who 
underwent the first follow-up MRI within 1 month after VPS via parieto-occipital approach were included in 
this study. Among them, 19 patients with iNPH (35%) had a comorbidity of AD, based on the comprehensive 
assessment of their symptoms, prescription of cholinesterase inhibitors, and findings on MRI and single-photon 
emission computed tomography, according to the current recommendation from the National Institute on 
Aging–Alzheimer’s Association workgroups35.
Ventriculo-peritoneal shunt and valve pressure adjustment. Details of the surgical procedure for 
VPS via parieto-occipital approach have been described in previously36. Briefly, to insert the ventricular catheter 
precisely, we routinely conducted preoperative virtual 3D simulation by using the SYNAPSE 3D workstation 
(Fujifilm Medical Systems, Tokyo, Japan). A shunt valve system including a Codman Hakim programmable valve 
Characteristics Pre-shunt (n = 54) Early (n = 54) Mid (n = 28) Late (n = 16)
Evans index (mean ± SD) 0.32 ± 0.06 0.31 ± 0.06 0.33 ± 0.06 0.34 ± 0.05
z-Evans index (mean ± SD) 0.44 ± 0.06 0.42 ± 0.05 0.41 ± 0.05 0.41 ± 0.06
Callosal angle (mean ± SD) 63.5 ± 18.5 72.0 ± 19.6 83.5 ± 24.2 84.5 ± 20.0
BVR at the AC (mean ± SD) 0.72 ± 0.17 0.79 ± 0.16 0.83 ± 0.15 0.84 ± 0.19
BVR at the PC (mean ± SD) 0.89 ± 0.23 1.10 ± 0.25 1.07 ± 0.30 1.09 ± 0.24
CVR (mean ± SD) 0.47 ± 0.20 0.60 ± 0.29 0.66 ± 0.23 0.72 ± 0.31
Brain parenchyma, mL (VR, %) 1107 (71.8) 1131 (73.4) 1116 (73.3) 1099 (73.9)
Total CSF, mL (VR, %) 436.8 (28.2) 412.4 (26.6) 408.7 (26.7) 389.4 (26.1)
Total ventricle, mL (VR, %) 163.7 (10.5) 144.5 (9.3) 141.2 (9.2) 139.4 (9.3)
Bilateral ventricle, mL (VR, %) 155.0 (10.0) 136.3 (8.8) 134.1 (8.8) 135.8 (9.0)
Third ventricle, mL (VR, %) 5.2 (0.3) 4.8 (0.3) 4.3 (0.3) 4.1 (0.3)
Fourth ventricle, mL (VR, %) 3.6 (0.2) 3.3 (0.2) 2.9 (0.2) 2.5 (0.2)
Total SAS, mL (VR, %) 273.1 (17.7) 267.9 (17.3) 267.4 (17.5) 250.0 (16.9)
Convex part of the SAS, mL (VR, %) 72.3 (4.7) 80.2 (5.2) 88.1 (5.7) 92.7 (6.2)
Sylvian fissure and basal cistern, mL (VR, %) 130.2 (8.4) 120.7 (7.8) 116.1 (7.6) 100.1 (6.8)
SAS in the posterior fossa, mL (VR, %) 70.6 (4.6) 68.9 (4.4) 63.5 (4.1) 56.5 (3.8)
Table 3. Mean values of indices and volumes on MRI before and after shunt surgery. *Values with significant 
changes from the pre-shunt values by the Wilcoxon signed-rank test. AC, anterior commissure; BVR, brain 
per ventricle ratio; CSF, cerebrospinal fluid; CVR, convex subarachnoid space to ventricle ratio; MRI, magnetic 
resonance imaging; PC, posterior commissure; SAS, subarachnoid space; SD, standard deviation; VR, volume 
ratio.
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with a Siphon-Guard® (Integra LifeSciences Corporation, Plainsboro, NJ, USA) was used in 12 patients until 
March 2016; after that date, 42 patients underwent VPS by using an MRI-resistant Codman CERTAS® Plus pro-
grammable valve with a Siphon-Guard® (Integra LifeSciences Corporation, Plainsboro, NJ, USA). The mean 
values of age, several indices, and volumes were not significantly different between the two groups. The opening 
pressure of the shunt valve was set based on the patient’s height and weight per Miyake’s quick reference table37. 
All patients were evaluated for over- or underdrainage of CSF based on the changes in the symptoms and CT scan 
within 10 days after shunt implantation, and subsequently, every 1 month up to 6 months and every 3 months 
after 6 months. The valve pressure was readjusted in stepwise setting for the Codman CERTAS Plus valve or by 
intervals of 2 cmH2O for the Codman Hakim programmable valve as required. Concretely, in case of insuffi-
cient improvement of patients’ symptoms, defined as CSF underdrainage, the valve pressure was lowered; in case 
of orthostatic headache or subdural effusion on CT scan, defined as CSF overdrainage, the valve pressure was 
raised. If the valve pressure was readjusted, we checked the patients’ conditions and subdural effusion through 
CT scan within 1 month after readjustment. In this study, the follow-up MRI finding of apparent subdural effu-
sion or hematoma was absent, and no patient required additional surgery for subdural hematoma during the 
follow-up period. Clinical outcomes were classified into excellent, good, and unsatisfactory36. An excellent out-
come was defined as the regained ability to perform outdoor activities that was grade 0 to 2 on the modified 
Rankin Scale and a ≥ 2-point improvement on the Japanese iNPH grading scale. A good outcome was defined as a 
1-point improvement on the modified Rankin Scale or iNPH grading scale but needing some support to perform 
Figure 2. Bee swarm plots of the changing rate of indices and segmented volumes following shunt surgery 
compared to those at baseline magnetic resonance imaging. Graph A shows the distribution and mean value 
of the relative changes in the following indices; Evans index (brown), z-Evans index (green), callosal angle 
(red), brain per ventricle ratio (BVR) at the anterior commissure (AC) level (purple) and BVR at the posterior 
commissure (PC) level (blue), and convexity subarachnoid space (SAS) per ventricle ratio (CVR; orange). 
Graph B shows the distribution and mean value of the relative volume changes in the brain parenchyma 
(brown), total ventricles (red), and total SAS (blue). Graph C shows the distribution and mean value of the 
relative volume changes in the convexity part of SAS (blue), Sylvian fissure and basal cistern (red), and SAS in 
the posterior fossa (brown).
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outdoor activities, which was graded 3 to 4 on the modified Rankin Scale. An unsatisfactory outcome was 
defined as unchanged or worsening symptoms and persistent severe disability that was grade 5 on the modified 
Rankin Scale. Table 4 shows the changes in modified Rankin Scale, iNPH grading scale, times on the 3-m timed 
up-and-go test and 10-m straight walk test and scores of mini-mental state examination and frontal assessment 
battery at the baseline MRI and the first follow-up MRI. The patients with excellent outcome had significantly 
mild grade on the baseline modified Rankin Scale and significant improvement on modified Rankin Scale at the 
first follow-up MRI, compared with those with good outcome. Additionally, the patients with excellent outcome 
significantly improved the total and gait scores of iNPH grading scale at the first follow-up MRI, compared with 
the patients with good outcome. However, the mean values and changes of quantitative measurements did not 
have significant differences between the excellent and good outcomes. The mean time on 3-m timed up-and-go 
test was shortened by >10 seconds at the first follow-up MRI in both groups of the excellent and good outcomes.
image acquisition and volumetric analysis. Because all patients had shunt valve placement under the 
right occipital scalp, MRI artefacts due to the shunt valve system on the T2-weighted 3D sequence slightly affected 
the CSF volume of the subarachnoid space in the posterior fossa (Fig. 6). The volumetric data were entered on a 
3D workstation, where the intracranial space was semi-automatically segmented with recent technologies com-
bined the user-steered live-wire segmentation, edge-guided nonlinear interpolation, and automatic extraction of 
Figure 3. Comparison of indices and segmented volumes after shunt surgery between patients with excellent 
outcome and those with good outcome. Asterisk (*) indicates statistically significant difference between the 
patients with excellent outcome (solid line) and those with good outcome (dotted line). Graph A shows the 
mean value of the relative changes in the following indices: Evans index (brown), z-Evans index (green), callosal 
angle (red), brain per ventricle ratio (BVR) at the anterior commissure (AC) level (purple) and BVR at the 
posterior commissure (PC) level (blue), and convexity subarachnoid space (SAS) per ventricle ratio (CVR; 
orange). Graph B show the mean value of the relative volume changes in the brain parenchyma (brown), total 
ventricles (red), and total subarachnoid space (SAS; blue). Graph C shows the mean value of the relative volume 
changes in the convexity part of SAS (blue), Sylvian fissure and basal cistern (red), and SAS in the posterior 
fossa (brown).
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continuous objects. After that, the intracranial space was subdivided into the brain parenchyma and intracranial 
CSF space through a simple threshold algorithm. Finally, the intracranial CSF spaces were manually segmented 
into the total ventricles, convexity subarachnoid space, Sylvian fissure and basal cistern, and subarachnoid space 
in the posterior fossa (Fig. 6 and Video). Each segmented volume was automatically measured by counting the 
number of voxels. Volume ratios, which were calculated as the measured volumes divided by the intracranial 
volume, were analyzed to eliminate the effect of head size.
Morphological indices specific to NPH. Figure 7 shows the measured indices early after VPS in the same 
patient with co-occurrence of iNPH and AD as Fig. 6. The Evans index (Fig. 7A) was measured as the maximal 
width of the frontal horns of the lateral ventricles to the maximal width of the internal diameter of the cranium 
based on the x-dimension38. The z-Evans index (Fig. 7B) was measured as the maximum z-axial length of the 
frontal horns of the lateral ventricles to the maximum cranial z-axial length on the coronal plane, which was 
perpendicular to the anteroposterior commissure plane on the AC7. The callosal angle (Fig. 7C) was measured as 
the angle of the roof of the bilateral ventricles on the coronal plane at the PC level5. The BVRs at the AC and PC 
levels (Fig. 7B,C) were calculated as the maximum width of the brain just above the lateral ventricles divided by 
Figure 4. Comparison of indices and segmented volumes after shunt surgery between patients with pure 
idiopathic normal pressure hydrocephalus (iNPH) and those with co-occurrence of iNPH and Alzheimer’s 
disease (AD) (iNPH + AD). Filled diamonds and solid lines indicate the patients with pure iNPH and unfilled 
diamonds and dotted lines indicate those with iNPH + AD. Graph A shows the mean value of the relative 
changes in the following indices; Evans index (brown), z-Evans index (green), callosal angle (red), brain per 
ventricle ratio (BVR) at the anterior commissure (AC) level (purple) and BVR at the posterior commissure 
(PC) level (blue), and convexity subarachnoid space (SAS) per ventricle ratio (CVR; orange). Graph B shows 
the mean value of the relative volume changes in the brain parenchyma (brown), total ventricles (red), and total 
subarachnoid space (SAS; blue). Graph C shows the mean value of the relative volume changes in the convexity 
part of SAS (blue), Sylvian fissure and basal cistern (red), and SAS in the posterior fossa (brown).
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the maximum width of the lateral ventricles on the reference coronal planes at the AC and PC levels, respectively8. 
The CVR was defined as the volume of the convexity-subarachnoid space divided by the total ventricular volume8.
Absolute and relative changes in the morphological indices and volumes in brain parenchyma, total ventricles, 
and three parts of subarachnoid spaces after VPS were compared to those before VPS. Absolute changes were 
calculated as the baseline indices and volumes minus those after VPS, and relative changes were calculated as the 
absolute changes divided by the baseline indices or volumes × 100 (%).
Statistical analysis. Absolute and relative changes in mean values and standard deviations (SDs) for the 
segmented volumes and indices after VPS were compared using Wilcoxon signed-rank test. The frequency of 
follow-up MRI examinations and the period from VPS to MRI varied widely: 54 patients underwent the first 
follow-up MRI from 5 to 29 days (median: 11 days) after VPS, 32 patients underwent the second MRI from 36 
Figure 5. Schematic diagram showing the longitudinal change of CSF in patients with iNPH. The iNPH-
specific CSF distribution named disproportionately enlarged subarachnoid space hydrocephalus (DESH) 
before shunting (left) reverted to a normal distribution in the following three phases; early, mid, and late after 
ventriculoperitoneal shunt surgery.
Excellent (n = 43) Good (n = 11) P value*
At baseline At 1st MRI At baseline At 1st MRI
mRS 2.57 ± 0.67 1.84 ± 0.69 2.82 ± 0.98 2.55 ± 0.82 0.012
∆mRS 0.72 ± 0.55 0.27 ± 0.47 0.026
iNPHGS total 6.36 ± 1.96 4.28 ± 1.92 6.36 ± 2.50 5.45 ± 2.81 0.118
∆total 2.07 ± 1.47 0.91 ± 1.45 0.007
gait 2.52 ± 0.51 1.56 ± 0.59 2.45 ± 0.69 2.09 ± 0.94 0.024
∆gait 0.98 ± 0.46 0.36 ± 0.67 <0.001
cognitive 1.83 ± 0.88 1.44 ± 0.80 2.00 ± 0.89 1.73 ± 0.90 0.255
∆cognitive 0.37 ± 0.62 0.27 ± 0.47 0.743
urinary 2.00 ± 0.96 1.28 ± 0.85 1.91 ± 1.30 1.64 ± 1.21 0.387
∆urinary 0.72 ± 0.77 0.27 ± 0.47 0.060
TUG 26.2 ± 30.4 13.5 ± 10.0 32.9 ± 33.7 16.7 ± 7.67 0.058
∆TUG 12.7 ± 29.4 16.4 ± 27.0 0.761
10 M Walk 18.4 ± 17.3 10.2 ± 15.5 19.7 ± 20.9 12.2 ± 6.72 0.195
∆10 M Walk 8.2 ± 15.8 7.6 ± 21.3 0.232
MMSE 21.6 ± 5.6 23.6 ± 5.0 21.5 ± 6.7 23.1 ± 5.1 0.777
∆MMSE 1.7 ± 4.5 2.2 ± 2.6 0.986
FAB 9.58 ± 2.9 11.4 ± 3.1 10.0 ± 4.1 10.5 ± 3.5 0.573
∆FAB 1.7 ± 2.8 0.7 ± 3.2 0.240
Table 4. Change in clinical scores at the baseline and the first follow-up MRI in the groups of excellent outcome 
and good outcome. Data are presented as the mean ± standard deviation unless otherwise noted. ∆ indicates the 
difference between score at the baseline and that at the first follow-up MRI. *Probability value of the Wilcoxon 
rank-sum test: comparison between excellent and good outcomes mRS, modified Rankin Scale; iNPHGS, 
idiopathic normal pressure hydrocephalus grading scale; TUG, timed 3-m up-and-go test; 10 M Walk, 10-m 
straight walking test; MMSE, mini-mental state examination; FAB, frontal assessment battery.
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Figure 6. Segmentation of the total ventricles and three parts of the subarachnoid spaces. These images were 
created on the SYNAPSE 3D workstation (Fujifilm Medical Systems, Tokyo, Japan) from a three-dimensional 
(3D) T2-weighted 3-Tesla sequence 10 days after ventriculoperitoneal shunting via parieto-occipital approach in 
a patient diagnosed with co-occurrence of idiopathic normal pressure hydrocephalus (iNPH) and Alzheimer’s 
disease (AD). The ventricles were manually extracted from intracranial cerebrospinal fluid (CSF) space by 
enclosing in a free shape. (A) The total subarachnoid spaces were segmented by subtraction of the total ventricles 
from total intracranial CSF spaces. The convexity subarachnoid space (B) was manually segmented from the total 
subarachnoid spaces per the anatomical landmarks of the basal interhemispheric cistern, Sylvian fissure, and 
tentorium cerebelli. From the residual subarachnoid spaces, the subarachnoid space in the posterior fossa (D) was 
segmented with reference to the anatomical landmarks of the tentorium cerebelli, chiasma and optic tract. There was 
a small MRI artefact in the right occipital posterior fossa. The Sylvian fissure and basal cistern (C) were segmented 
by subtraction of the convexity subarachnoid space and subarachnoid space in the posterior fossa from the total 
subarachnoid spaces. The convexity subarachnoid space per ventricle ratio (CVR), which was defined as the volume 
of the convexity subarachnoid space (178 mL) divided by the total ventricular volume (118 mL), was 1.51.
1 1Scientific RepoRtS |         (2019) 9:17318  | https://doi.org/10.1038/s41598-019-53888-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Figure 7. Morphological indices specific to idiopathic normal pressure hydrocephalus (iNPH). These magnetic 
resonance images are shown for the same patient as Fig. 6. The Evans index was calculated as 0.327 (A); the 
maximum length of the frontal horns of the lateral ventricles (46.0 mm) divided by the maximum cranial length 
on the same axial plane (140.8 mm). The z-Evans index, which was calculated as the maximum z-axial length 
of the frontal horns of the lateral ventricles (35.6 mm) divided by the maximum cranial z-axial length at the 
midline (88.0 mm) on the coronal plane just on the anterior commissure (AC), was 0.405 (B). The callosal angle 
was calculated as 63 degrees (C) at the roof of the bilateral ventricles on the coronal plane just on the posterior 
commissure (PC). The brain per ventricle ratios (BVRs) at the AC and PC levels were calculated as 0.941 (B) 
and 1.429 (C), respectively.
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to 742 days (median: 178 days), 12 patients underwent the third MRI from 366 to 1270 days (median: 559 days). 
Therefore, we categorized the period from VPS to follow-up MRI into <1 month (early, 54 patients), 1 month 
to 1 year (mid, 28 patients), and >1 year (late, 16 patients). The Wilcoxon rank-sum test was used to compare 
the mean values between patients with and without AD. Fisher’s exact test was used to compare the proportions 
of the 2 groups. Statistical significance was assumed at a probability (P) value of less than 0.05. All missing data 
were treated as deficit data that did not affect other variables. Statistical analysis was performed using R software 
(version 3.3.2; R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org).
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